Dr. Huang received his Ph.D. in Biophysics at Michigan State University. He was previously at the University of Tennessee, Knoxville (1976 – 1991) and at the University of Pittsburgh (1991 – 2005) as a faculty member. In July 2005, he was appointed Fred N. Eshelman Distinguished Professor and Chair, Division of Molecular Pharmaceutics at UNC School of Pharmacy. He has published over 280 peer-reviewed articles, over 100 invited reviews/book chapters, and has co- edited two books. The Laboratory of Drug Targeting, now also located at UNC, has been working on liposomes and immunoliposomes for drug delivery. Current activities are focused in the development of non-viral vectors for gene (including oligonucleotides) therapy, and receptor mediated drug and vaccine targeting using self-assembled nanoparticles. The technologies are tested for therapy of cancer and other diseases in animal models.

Recent publications on PubMed